2-Chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 178487420, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:17])[CH2:13][CH:14]([CH3:16])[CH3:15])=[C:5]2[NH:18][C@H:19]1[CH2:24][CH2:23][C@H:22]([N:25]([CH3:27])[CH3:26])[CH2:21][CH2:20]1.[Cl:28][C:29]1[CH:34]=[C:33](B2OC(C)(C)C(C)(C)O2)[CH:32]=[C:31]([O:44][CH3:45])[C:30]=1[OH:46]>>[Cl:28][C:29]1[CH:34]=[C:33]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:17])[CH2:13][CH:14]([CH3:15])[CH3:16])=[C:5]3[NH:18][C@H:19]2[CH2:24][CH2:23][C@H:22]([N:25]([CH3:27])[CH3:26])[CH2:21][CH2:20]2)[CH:32]=[C:31]([O:44][CH3:45])[C:30]=1[OH:46]Participants
3
Procedure
Following general procedure D, 1-{6-bromo-4-[trans-4-(dimethylamino)cyclohexylamino]quinolin-3-yl}-3-methylbutan-1-one (13 mg, 0.030 mmol) was reacted with 2-chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (21 mg, 0.075 mmol) to afford the desired product (8.8 mg, 58%) as a yellow solid: NMR (500 MHz, CD3OD) δ 8.94 (s, 1H), 8.35 (d, J=1.8 Hz, 1H), 8.03 (dd, J=8.7, 1.9 Hz, 1H), 7.90 (d, J=8.7 Hz, 1H), 7.29 (d, J=2.1 Hz, 1H), 7.22 (d, J=2.1 Hz, 1H), 4.24 (t, J=10.8 Hz, 1H), 3.99 (s, 3H), 2.94 (d, J=7.0 Hz, 2H), 2.82 (s, 1H), 2.53 (s, 6H), 2.42 (d, J=12.0 Hz, 2H), 2.33-2.21 (m, 1H), 2.14 (d, J=12.0 Hz, 2H), 1.72-1.53 (m, 4H), 1.03 (d, J=6.7 Hz, 6H); ESI MS m/z 510 [C29H36ClN3O3+H]+; HPLC>99% (AUC), tR=11.38 min.
Sources & evidence
- ORD record
- ord-6e53f7b2b3c044b698070e8e374f095d
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…